Last viewed: IPHYF


Prices are updated after-hours


nasdaq:IPHYF Innate Pharma SA

IPHYF | $2.6 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-14.2% 1m) (-59.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-99.14% volume)
Earnings Calendar:
http://www.innate-pharma.com/en
Sec Filling | Patents | n/a employees

(FR) Innate Pharma SA is a biopharmaceutical company. It focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. Its products include immunotherapy drugs and monoclonal antibodies. The Immunotherapy drugs are designated for cancer and inflammatory diseases. The Monoclonal antibodies targets receptors and pathways controlling the activation of innate immunity cells. The company was founded by Hervé Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié and François Romagné on September 15, 1999 and is headquartered in Marseille, France.

cancer   immunotherapy   antibody   t-cell   treatment   ceiling   cancer treatments  

add to watch list email alert is off

Price chart


% (High / Open) change chart




Press-releases


Innate Pharma to Participate in Upcoming Investor Conference - June 23, 2022
Published: 2022-06-23 (Crawled : 07:00) - biospace.com/
SNY | News | $52.14 -0.88% -0.38% | twitter stocktwits trandingview |
Health Technology
| | O: 1.85% H: 0.0% C: 0.0%
NVO | News | $108.3 -4.07% -0.25% | twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 1.34% C: 1.31%
IPHA | $2.8 2.19% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -1.85% H: 3.02% C: -1.13%

pharma conference
Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer
Published: 2022-06-03 (Crawled : 08:00) - biospace.com/
IPHA | $2.8 2.19% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 2.96% H: 0.98% C: -1.15%
SNY | News | $52.14 -0.88% -0.38% | twitter stocktwits trandingview |
Health Technology
| | O: -0.09% H: 0.0% C: 0.0%
AZN | $65.93 -0.87% 0.12% | twitter stocktwits trandingview |
Health Technology
| | O: -0.56% H: 0.82% C: -0.64%
NVO | News | $108.3 -4.07% -0.25% | twitter stocktwits trandingview |
Health Technology
| | O: 0.65% H: 0.63% C: 0.16%
IPHYF | $2.6 | twitter stocktwits trandingview |
Health Technology
| | O: 1.65% H: 0.0% C: -0.32%
SNYNF | News | $108.84 4.15% | twitter stocktwits trandingview |
Health Technology
| | O: -0.94% H: 0.0% C: 0.0%

iph5201 pharma cancer
Innate Pharma to Participate in Upcoming Investor Conferences - May 11, 2022
Published: 2022-05-11 (Crawled : 09:00) - biospace.com/
IPHA | $2.8 2.19% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 5.34% H: 1.75% C: -1.4%
NVO | News | $108.3 -4.07% -0.25% | twitter stocktwits trandingview |
Health Technology
| | O: -2.55% H: 2.32% C: -0.85%
SNY | News | $52.14 -0.88% -0.38% | twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.0% C: 0.0%

pharma
Innate Pharma Reports First Quarter 2022 Financial Results and Business Update
Published: 2022-05-10 (Crawled : 07:00) - biospace.com/
IPHA | $2.8 2.19% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -0.37% H: 2.23% C: 0.93%
NVO | News | $108.3 -4.07% -0.25% | twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 0.0% C: 0.0%
SNY | News | $52.14 -0.88% -0.38% | twitter stocktwits trandingview |
Health Technology
| | O: 1.06% H: 0.0% C: 0.0%

pharma results
Innate Pharma Announces Conference Call and Webcast for Q1 2022 Business Update
Published: 2022-05-03 (Crawled : 08:00) - biospace.com/
NVO | News | $108.3 -4.07% -0.25% | twitter stocktwits trandingview |
Health Technology
| | O: -0.59% H: 0.96% C: -0.04%
SNY | News | $52.14 -0.88% -0.38% | twitter stocktwits trandingview |
Health Technology
| | O: 1.21% H: 0.0% C: 0.0%
IPHA | $2.8 2.19% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 1.4% H: 1.38% C: -0.35%

pharma conference for
Innate Pharma: First Patient Dosed in Monalizumab Phase 3 Lung Cancer Clinical Trial Triggers $50M Payment From AstraZeneca
Published: 2022-04-29 (Crawled : 11:00) - biospace.com/
NVO | News | $108.3 -4.07% -0.25% | twitter stocktwits trandingview |
Health Technology
| | O: 5.98% H: 1.44% C: -0.42%
SNY | News | $52.14 -0.88% -0.38% | twitter stocktwits trandingview |
Health Technology
| | O: 1.93% H: 0.0% C: 0.0%
AZN | $65.93 -0.87% 0.12% | twitter stocktwits trandingview |
Health Technology
| | O: 0.53% H: 2.37% C: 0.26%
SNYNF | News | $108.84 4.15% | twitter stocktwits trandingview |
Health Technology
| | O: 0.48% H: 0.24% C: 0.24%
IPHA | $2.8 2.19% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 11.11% H: 3.67% C: -4.33%

trial payment cancer phase 3
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 20, 2022
Published: 2022-04-08 (Crawled : 07:00) - biospace.com/
IPHA | $2.8 2.19% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 3.55% H: 0.0% C: -1.87%
SNYNF | News | $108.84 4.15% | twitter stocktwits trandingview |
Health Technology
| | O: 1.75% H: 0.0% C: 0.0%
SNY | News | $52.14 -0.88% -0.38% | twitter stocktwits trandingview |
Health Technology
| | O: 2.1% H: 0.0% C: 0.0%
NVO | News | $108.3 -4.07% -0.25% | twitter stocktwits trandingview |
Health Technology
| | O: -1.49% H: 1.22% C: 0.47%

pharma
Innate Pharma Files Its 2021 Universal Registration Document (Document d’enregistrement universel) and 2021 Annual Report on Form 20-F
Published: 2022-04-05 (Crawled : 07:00) - biospace.com/
NVO | News | $108.3 -4.07% -0.25% | twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 1.02% C: 0.31%
SNY | News | $52.14 -0.88% -0.38% | twitter stocktwits trandingview |
Health Technology
| | O: 0.64% H: 0.0% C: 0.0%
SNYNF | News | $108.84 4.15% | twitter stocktwits trandingview |
Health Technology
| | O: -0.75% H: 0.0% C: 0.0%
IPHA | $2.8 2.19% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 0.86% H: 0.0% C: -3.43%

pharma report
Innate Pharma Reports Full Year 2021 Financial Results and Business Update
Published: 2022-03-24 (Crawled : 08:00) - biospace.com/
IPHA | $2.8 2.19% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -3.17%
BNPQY | News | $24.99 -0.99% | twitter stocktwits trandingview |
Finance and Insurance
| | O: -0.98% H: 1.17% C: 0.78%
NVO | News | $108.3 -4.07% -0.25% | twitter stocktwits trandingview |
Health Technology
| | O: -1.27% H: 0.98% C: 0.93%
SNY | News | $52.14 -0.88% -0.38% | twitter stocktwits trandingview |
Health Technology
| | O: 0.05% H: 0.0% C: 0.0%

results pharma
Innate Pharma Announces Conference Call and Webcast for Full Year 2021 Financial Results
Published: 2022-03-17 (Crawled : 07:00) - biospace.com/
NVO | News | $108.3 -4.07% -0.25% | twitter stocktwits trandingview |
Health Technology
| | O: 2.33% H: 0.0% C: 0.0%
SNY | News | $52.14 -0.88% -0.38% | twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.0% C: 0.0%
SNYNF | News | $108.84 4.15% | twitter stocktwits trandingview |
Health Technology
| | O: -1.62% H: 0.0% C: 0.0%
IPHA | $2.8 2.19% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 1.51% H: 2.38% C: 2.08%

financial results conference results pharma
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Last 48 Hours Insiders Buying
ALTG P 3227 | $9.29 -2.52% 0.0% | twitter stocktwits trandingview |
Distribution Services
| 01:40
SKIL P 30000 | $3.61 -6.96% 2.22% | twitter stocktwits trandingview |
Information
| 23:50
CAMP P 20000 | $4.65 -1.27% 0.86% | twitter stocktwits trandingview |
Electronic Technology
| 16:00